Ticker Launch
Sign inGet notified

SPAC · Deal announced · APXI

APx Acquisition Corp. I

Business combination with OmnigenicsAI Corp

APx Acquisition Corp. I (APXI) is a blank-check company (SPAC) that raised $150M in its initial public offering on Dec 8, 2021, listing on Nasdaq. It agreed to combine with OmnigenicsAI Corp, announced on Mar 25, 2024, at a stated value of $340M. The deal has not closed yet. AC Capital led the IPO, with VRE Capital. Davis Polk advised the SPAC and A&O Shearman advised the underwriters on the IPO.

Status
Deal announced
Ticker
APXI
IPO date
Dec 8, 2021
IPO size
$150M
IPO exchange
Nasdaq
Target
OmnigenicsAI Corp
Target sector
Other
Announced
Mar 25, 2024
Stated deal value
$340M
Combined company
OmnigenicsAI Corp
IPO underwriters
AC Capital and VRE Capital
SPAC counsel (IPO)
Davis Polk and Maples and Calder
Underwriters' counsel (IPO)
A&O Shearman

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Get notified at launchOpen in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Other pending SPAC mergers